Annual Cash & Cash Equivalents
$80.34 M
+$28.12 M+53.86%
December 31, 2023
Summary
- As of February 7, 2025, FHTX annual cash & cash equivalents is $80.34 million, with the most recent change of +$28.12 million (+53.86%) on December 31, 2023.
- During the last 3 years, FHTX annual cash & cash equivalents has fallen by -$12.46 million (-13.43%).
- FHTX annual cash & cash equivalents is now -20.57% below its all-time high of $101.14 million, reached on December 31, 2021.
Performance
FHTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$57.68 M
-$81.27 M-58.49%
September 30, 2024
Summary
- As of February 7, 2025, FHTX quarterly cash and cash equivalents is $57.68 million, with the most recent change of -$81.27 million (-58.49%) on September 30, 2024.
- Over the past year, FHTX quarterly cash and cash equivalents has dropped by -$12.63 million (-17.96%).
- FHTX quarterly cash and cash equivalents is now -73.00% below its all-time high of $213.65 million, reached on March 31, 2022.
Performance
FHTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
FHTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +53.9% | -18.0% |
| 3 y3 years | -13.4% | +13.9% |
| 5 y5 years | +100.7% | +13.9% |
FHTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.6% | +53.9% | -73.0% | +13.9% |
| 5 y | 5-year | -20.6% | +436.3% | -73.0% | +285.0% |
| alltime | all time | -20.6% | +436.3% | -73.0% | +285.0% |
Foghorn Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $57.68 M(-58.5%) |
| Jun 2024 | - | $138.95 M(+75.3%) |
| Mar 2024 | - | $79.25 M(-1.3%) |
| Dec 2023 | $80.34 M(+53.9%) | $80.34 M(+14.3%) |
| Sep 2023 | - | $70.31 M(+21.8%) |
| Jun 2023 | - | $57.70 M(+13.9%) |
| Mar 2023 | - | $50.64 M(-3.0%) |
| Dec 2022 | $52.21 M | $52.21 M(-40.4%) |
| Sep 2022 | - | $87.60 M(+43.1%) |
| Jun 2022 | - | $61.21 M(-71.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $213.65 M(+111.2%) |
| Dec 2021 | $101.14 M(+9.0%) | $101.14 M(+74.9%) |
| Sep 2021 | - | $57.84 M(-53.8%) |
| Jun 2021 | - | $125.17 M(+88.4%) |
| Mar 2021 | - | $66.45 M(-28.4%) |
| Dec 2020 | $92.80 M(+519.4%) | $92.80 M(+24.4%) |
| Sep 2020 | - | $74.62 M(+104.1%) |
| Jun 2020 | - | $36.56 M(+144.1%) |
| Dec 2019 | $14.98 M(-62.6%) | $14.98 M |
| Dec 2018 | $40.02 M | - |
FAQ
- What is Foghorn Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual cash & cash equivalents year-on-year change?
- What is Foghorn Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Foghorn Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of FHTX is $80.34 M
What is the all time high annual cash & cash equivalents for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual cash & cash equivalents is $101.14 M
What is Foghorn Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, FHTX annual cash & cash equivalents has changed by +$28.12 M (+53.86%)
What is Foghorn Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FHTX is $57.68 M
What is the all time high quarterly cash and cash equivalents for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly cash and cash equivalents is $213.65 M
What is Foghorn Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, FHTX quarterly cash and cash equivalents has changed by -$12.63 M (-17.96%)